title: Gabapentin in the treatment of severe sweating experienced by advanced cancer patients.
abstract: Nine patients with advanced cancer suffering from idiopathic severe sweating were treated with gabapentin (600-1,800 mg/day). All patients responded to the treatment; five patients experienced transient drowsiness. Gabapentin seems to be a safe and effective treatment for idiopathic sweating in advanced cancer patients. Further studies are warranted to confirm or refute these results.
authors.affiliation: Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy. porzio1@interfree.it
authors.forename: Giampiero
authors.initials: G
authors.lastname: Porzio
authors.forename: Federica
authors.initials: F
authors.lastname: Aielli
authors.forename: Lucilla
authors.initials: L
authors.lastname: Verna
authors.forename: Claudio
authors.initials: C
authors.lastname: Porto
authors.forename: Paolo
authors.initials: P
authors.lastname: Aloisi
authors.forename: Katia
authors.initials: K
authors.lastname: Cannita
authors.forename: Enrico
authors.initials: E
authors.lastname: Ricevuto
authors.forename: Paolo
authors.initials: P
authors.lastname: Marchetti
authors.forename: Corrado
authors.initials: C
authors.lastname: Ficorella
mesh_terms: D000328:Adult; D000368:Aged; D000588:Amines / Q000008:administration & dosage / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D007558:Italy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000503:physiopathology*; D013546:Sweating / Q000187:drug effects*; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000588:Amines; D014151:Anti-Anxiety Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin